SCHEMBL4980327

SCHEMBL4980327

O=C(C1CCCCCC1)N1CCc2c(ncnc2N2CCN(C3CCC3)CC2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
UBE2N P61088 2/20 0.41
KEAP1 Q14145 1/20 0.41
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
HIF1A Q16665 1/20 0.39
PIK3CA P42336 1/20 0.38
MTOR P42345 1/20 0.38
ACACB O00763 3/20 0.38
ACACA Q13085 3/20 0.38
P2RX7 Q99572 1/20 0.38
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
GAA P10253 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
THRB P10828 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975425 1.00 HRH1 (0.41) HRH1HRH3UBE2NKEAP1ALDH1A1
SCHEMBL4978437 0.99 HRH1 (0.42) HRH1HRH3UBE2NKEAP1ALDH1A1
SCHEMBL4978472 0.98 HRH3 (0.40) HRH1HRH3UBE2NKEAP1PIK3CA
SCHEMBL4974693 0.96 HRH3 (0.40) HRH1HRH3UBE2NALDH1A1LMNA
SCHEMBL4974946 0.87 GRM5 (0.39) HRH1HRH3UBE2NPIK3CAP2RX7
SCHEMBL4982019 0.85 ADORA2A (0.46) HRH1HRH3ALDH1A1LMNAHTT
SCHEMBL4977192 0.85 ALDH1A1 (0.46) HRH1HRH3ALDH1A1LMNAHTT
SCHEMBL4979872 0.83 ADORA2A (0.47) HRH1HRH3ALDH1A1LMNAHTT
SCHEMBL4980362 0.83 HRH3 (0.39) HRH1HRH3ALDH1A1LMNAHTT
SCHEMBL4974700 0.83 TLR7 (0.40) HRH1HRH3UBE2NALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
WO-2007146122-A2 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES HRH3, HRH4, HRH2 HRH1 4/4885HRH3 1/4885UBE2N 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.